Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
BiomX Inc. COmmon Stock
(NY:
PHGE
)
0.6657
-0.0916 (-12.10%)
Streaming Delayed Price
Updated: 11:18 AM EDT, Jun 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about BiomX Inc. COmmon Stock
Could the Next Breakthrough in Antibiotic Resistance Come From Viruses That Kill Bacteria?
October 28, 2025
Via
AB Newswire
Topics
Death
Next-Gen Leaders: SIGL, PHGE, OTRK, SGBX – Across Critical Sectors
August 06, 2025
Via
AB Newswire
Topics
Intellectual Property
Market Alert: BiomX Trading Surges Following Phase 2b Trial Initiation in Cystic Fibrosis Program
July 14, 2025
Via
AB Newswire
This $13M Biotech Has $40M in Pentagon Funding – Here’s Why BiomX Could Be Biotech’s Best-Kept Secret
June 26, 2025
This $13M Biotech Has $40M in Pentagon Funding – Here’s Why BiomX Could Be Biotech’s Best-Kept Secret
Via
News Direct
BiomX Stock Could Soar 3000% As This $10M Biotech Cracks The 'Superbug' Code, Wall Street Says
June 16, 2025
BiomX's breakthrough phage therapy delivers positive results in diseases that stumped Big Pharma for decades (NYSE: PHGE)*
Via
News Direct
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Advancing US FDA Process, Featured Among Top Health Care Movers
May 31, 2024
Via
AB Newswire
BiomX To Present at H.C. Wainwright 24th Annual Global Investment Conference
September 11, 2022
From
BiomX Inc.
Via
Business Wire
BiomX Reports Second Quarter 2022 Financial Results and Provides Business Update
August 10, 2022
From
BiomX Inc.
Via
Business Wire
BiomX to Host Second Quarter 2022 Financial Results Conference Call and Webcast on August 10, 2022
August 07, 2022
From
BiomX Inc.
Via
Business Wire
BiomX Announces Publication in Cell of Research Demonstrating Proof-of-Concept Assessment of Orally Administered Phage Treatment in Preclinical Model of Inflammatory Bowel Disease
August 04, 2022
From
BiomX
Via
Business Wire
BiomX Announces Voluntary Delisting from the Tel Aviv Stock Exchange
July 06, 2022
From
BiomX Inc.
Via
Business Wire
Boehringer Ingelheim and BiomX Collaborate to Discover Inflammatory Bowel Disease Microbiome Biomarkers
June 28, 2022
From
BiomX Inc.
Via
Business Wire
BiomX Announces Dosing of the First Two Patients in Phase 1b/2a Study of BX004 for Treatment of Chronic Respiratory Infections in Patients with Cystic Fibrosis
June 27, 2022
From
BiomX Inc.
Via
Business Wire
BiomX Announces Corporate Restructuring
May 24, 2022
From
BiomX Inc.
Via
Business Wire
BiomX Announces Publication in the Journal, Bioinformatics
May 20, 2022
From
BiomX Inc.
Via
Business Wire
BiomX Reports First Quarter 2022 Financial Results and Provides Business Update
May 11, 2022
From
BiomX Inc.
Via
Business Wire
BiomX to Host Key Opinion Leader Event on BX004 for Treatment of Pseudomonas Aeruginosa Infections in Cystic Fibrosis Patients
May 06, 2022
From
BiomX Inc.
Via
Business Wire
BiomX to Host First Quarter 2022 Financial Results Conference Call and Webcast on May 11, 2022
May 05, 2022
From
BiomX Inc.
Via
Business Wire
BiomX Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
March 30, 2022
From
BiomX Inc.
Via
Business Wire
BiomX to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call and Webcast on March 30, 2022
March 23, 2022
From
BiomX Inc.
Via
Business Wire
BiomX Presenting at Three Upcoming Investor Conferences
February 24, 2022
From
BiomX Inc.
Via
Business Wire
BiomX Announces Therapeutics Development Award of up to $5 Million from the Cystic Fibrosis Foundation
January 04, 2022
From
BiomX Inc.
Via
Business Wire
BiomX Presents Preclinical Results With BX005 for Atopic Dermatitis at the Revolutionizing Atopic Dermatitis 2021 Virtual Conference and the International Conference on Phage Therapy and Bacteriophages
June 14, 2021
From
BiomX Inc.
Via
Business Wire
BiomX to Present Preclinical Results with BX004 in Cystic Fibrosis at the 44th European Cystic Fibrosis Conference
June 09, 2021
From
BiomX Inc.
Via
Business Wire
BiomX Reports First Quarter 2021 Financial Results and Provides Business Updates
May 24, 2021
From
BiomX Inc.
Via
Business Wire
BiomX to Host First Quarter 2021 Financial Results Conference Call and Webcast on May 24, 2021
May 18, 2021
From
BiomX Inc.
Via
Business Wire
BiomX to Present at Upcoming April Investor Events
April 20, 2021
From
BiomX Inc.
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
